David Windley
Stock Analyst at Jefferies
(3.66)
# 559
Out of 4,829 analysts
189
Total ratings
66.06%
Success rate
13.67%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Hold | $64 → $61 | $62.79 | -2.85% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $17.11 | -29.87% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $249.53 | +1.39% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $6.15 | +241.46% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $299.21 | +15.30% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $333.46 | +26.55% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $322.20 | -7.82% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $148.99 | +62.43% | 4 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $380.64 | +69.98% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $1.96 | +91.33% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $404.58 | +49.29% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $536.51 | -30.10% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $13.13 | +18.05% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $237.05 | +13.90% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.98 | +29.38% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $213.06 | +151.57% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $24.00 | +20.83% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $138.79 | +46.26% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $133.96 | +125.44% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.11 | +3,388.05% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.59 | - | 5 | Oct 9, 2017 |
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $62.79
Upside: -2.85%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $17.11
Upside: -29.87%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $249.53
Upside: +1.39%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $6.15
Upside: +241.46%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $299.21
Upside: +15.30%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $333.46
Upside: +26.55%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $322.20
Upside: -7.82%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $148.99
Upside: +62.43%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $380.64
Upside: +69.98%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.96
Upside: +91.33%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $404.58
Upside: +49.29%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $536.51
Upside: -30.10%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $13.13
Upside: +18.05%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $237.05
Upside: +13.90%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.98
Upside: +29.38%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $213.06
Upside: +151.57%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $24.00
Upside: +20.83%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $138.79
Upside: +46.26%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $133.96
Upside: +125.44%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.11
Upside: +3,388.05%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.59
Upside: -